CJ

Chirag Jitendrabhai Sadhariya

Active Director Director DIN 09429998
DIN 09429998 First appointment Dec 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chirag Jitendrabhai Sadhariya

Data last updated:

Chirag Jitendrabhai Sadhariya is a Director at Pharmagic Lifesciences Private Limited (since 2021). The company operates in Healthcare.

DIN 09429998
Primary Designation Director
Industry Healthcare
First Appointment 09 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Dec 20212021Active

Directorship timeline

Open interactive timeline →
Pharmagic Lifesciences Private Limited
Premium access

Shareholding and investment profile for Chirag Jitendrabhai Sadhariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Jitendrabhai Sadhariya

Chirag Jitendrabhai Sadhariya currently holds 1 directorship: Pharmagic Lifesciences Private Limited (Director, since 09 Dec 2021).

Chirag Jitendrabhai Sadhariya was first appointed on 09 Dec 2021 as Director at Pharmagic Lifesciences Private Limited.

The current boards of Chirag Jitendrabhai Sadhariya's companies include Neimish Bharatbhai Ruparelia (Pharmagic Lifesciences Private Limited), Pankajkumar Popatbhai Sankhavara (Pharmagic Lifesciences Private Limited), Shivlal Ramjibhai Barejia (Pharmagic Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available